(Q34639628)

3 August 2017

1 reference

title

Antifungal and antiviral chemotherapy. (English)

1 reference

3 August 2017

1 reference

Thomas J Pallasch

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

240-255

1 reference

Prevention of cytomegalovirus disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

21 January 2018

Novel antifungal drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Cytomegalovirus: a virus of increasing relevance to oral medicine and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Herpes Simplex Virus Type 2 in the United States, 1976 to 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Emerging novel antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Viral and fungal infections of the oral cavity in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Betaherpesviruses in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Antiviral therapy of acute herpes zoster in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

What clinicians need to know about antiviral drugs and viral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Denture stomatitis — a review of the aetiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Genetic analysis of azole resistance in the Darlington strain of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Antifungal agents in the 1990s. Current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Antiviral agents for non-human immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Herpes simplex virus: the importance of asymptomatic shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Fungal cell wall inhibitors: emphasis on clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Sexual transmission and the natural history of human herpesvirus 8 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Point Prevalence of Oropharyngeal Carriage of Fluconazole‐ResistantCandidain Human Immunodeficiency Virus–Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

A review of oral fungal infections and appropriate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Psychologic stress and recurrent aphthous ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Herpes simplex: evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Antiviral drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Treatment of potentially life-threatening enterovirus infections with pleconaril

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

The ecology and pathology of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Oral shedding of herpes simplex virus type 1: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Recurrent aphthous stomatitis: current concepts of etiology, pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

ABC of oral health. Mouth ulcers and other causes of orofacial soreness and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Pathologic Studies of Fatal Cases in Outbreak of Hand, Foot, and Mouth Disease, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Recurrent aphthous stomatitis. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Chemotherapy of varicella zoster virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Antifungal agents. Part II. The azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Emerging Issues in Nosocomial Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

21 January 2018

Herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

Recurrent aphthous ulcers: a review of diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

21 January 2018

Varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Genital herpes: review of the epidemic and potential use of type-specific serology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Recurrence rates in genital herpes after symptomatic first-episode infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

1 reference

7 January 2021

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Long-term suppression of genital herpes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Oral manifestations of cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

In vitro activities of antimicrobial agents against Candida species

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Human herpesvirus-6: neurologic implications of a newly-described viral pathogen.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Resistance to amphotericin B: emerging clinical and microbiological patterns

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Antifungal combination therapy: where we stand

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Oral aspergillosis in compromised patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0757.2002.280110.X

7 January 2021

10.1034/J.1600-0757.2002.280110.X

Identifiers

DOI

1 reference

3 August 2017

1 reference